Cargando…

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.

Acute haematological toxicity induced by cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) (carboplatin) and cis-diamminedichloroplatinum (II) (cisplatin) in combination with whole body hyperthermia (WBH) (2 h at 41.5 degrees C) was examined using a F344 rat model. The thermal enhancement rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohno, S., Strebel, F. R., Stephens, L. C., Siddik, Z. H., Baba, H., Makino, M., Khokhar, A. R., Bull, J. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968409/ https://www.ncbi.nlm.nih.gov/pubmed/8353037

Ejemplares similares

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
por: Tapazoglou, E., et al.
Publicado: (1991)

Hemodynamics in induced whole body hyperthermia
por: Kerner, T, et al.
Publicado: (1998)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.
por: Benedetti Panici, P., et al.
Publicado: (1997)

Proceedings: The effect of whole body hyperthermia in advanced cancer.
por: Pettigrew, R. T., et al.
Publicado: (1974)

Thermal distribution, physiological effects and toxicities of extracorporeally induced whole‐body hyperthermia in a pig model
por: Lassche, Gerben, et al.
Publicado: (2020)

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
por: Helbekkmo, N, et al.
Publicado: (2007)

Whole-body hyperthermia in the treatment of breast cancer
por: Rethfeldt, E, et al.
Publicado: (2001)

Arterial blood pressure monitoring during whole body hyperthermia
por: Kerner, T, et al.
Publicado: (2002)

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
por: Los, G., et al.
Publicado: (1994)

The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice.
por: Walton, M. I., et al.
Publicado: (1987)

Changes in serum cytokine levels during induced whole body hyperthermia
por: Ahlers, O, et al.
Publicado: (1999)

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis
por: Nijstad, A. Laura, et al.
Publicado: (2020)

Whole body MRI and PET/CT in haematological malignancies
por: Lin, Chieh, et al.
Publicado: (2007)

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
por: Rantanen, V., et al.
Publicado: (1994)

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
por: Tang, Chi-Hui, et al.
Publicado: (2010)

Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
por: Liew, Mun Sem, et al.
Publicado: (2013)

Whole body hyperthermia, but not skin hyperthermia, accelerates brain and locomotor limb circulatory strain and impairs exercise capacity in humans
por: Trangmar, Steven J., et al.
Publicado: (2017)

Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.
por: Kusumoto, T., et al.
Publicado: (1993)

Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads
por: Allen, Caroline M, et al.
Publicado: (2020)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

Genotoxicity of cisplatin and carboplatin in cultured human lymphocytes: a comparative study
por: AZAB, Belal, et al.
Publicado: (2019)

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
por: Azar, Ibrahim, et al.
Publicado: (2022)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

Effects of cisplatin in combination with hyperthermia on biological characteristics of retroperitoneal liposarcoma
por: Miao, Cheng-Li, et al.
Publicado: (2021)

Chemical conversion of cisplatin and carboplatin with histidine in a model protein crystallized under sodium iodide conditions
por: Tanley, Simon W. M., et al.
Publicado: (2014)

The pulmonary and haematological toxicity of inhaled aerosolised prostacyclin
por: van Heerden, PV, et al.
Publicado: (1997)

Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020)

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
por: Groen, H. J., et al.
Publicado: (1995)

Alterations of metabolic and hemodynamic parameters during whole body hyperthermia on the ICU
por: Nierhaus, A, et al.
Publicado: (1999)

Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes
por: Rochet, Nathalie, et al.
Publicado: (2013)

Prevotella copri is associated with carboplatin-induced gut toxicity
por: Yu, Chaoheng, et al.
Publicado: (2019)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
por: Ding, Qian, et al.
Publicado: (2013)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
Publicado: (2018)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_en7smim9od6sc9mrolqtljhbaq